10-K/A: Health Catalyst Files Amended 10-K to Correct Internal Control Reporting Omissions
Annual Report Amendment
Health Catalyst has filed an amendment to its annual report to correct omissions in certifications related to internal control over financial reporting.
Summary
- Health Catalyst, Inc. filed an amendment to its annual report on Form 10-K to correct inadvertent omissions in the Section 302 Certifications of the company's principal executive officer and principal financial officer.
- The original filing on February 22, 2024, omitted introductory language in paragraph 4 and paragraph 4(b) regarding the design of internal control over financial reporting.
- The amendment includes resubmitted, corrected versions of Exhibits 31.1 and 31.2, which are the certifications of the CEO and CFO, respectively.
- This amendment does not reflect any events occurring after the original filing date and does not modify or update any other disclosures in the original Form 10-K.
Sentiment
Score: 4
Explanation: The document indicates a negative event (an error in the original filing) but also a positive response (the correction). The overall sentiment is slightly negative due to the initial error.
Positives
- The company promptly addressed and corrected the omissions in the original filing.
- The resubmitted certifications ensure compliance with SEC regulations.
Negatives
- The need for an amendment indicates a lapse in internal control procedures during the initial filing process.
Risks
- The initial omission of required information in the certifications could raise concerns about the effectiveness of the company's internal controls.
- Although corrected, such errors can lead to increased scrutiny from regulators and investors.
Future Outlook
This amendment does not include any forward-looking statements or guidance.
Management Comments
- Daniel Burton, CEO, and Jason Alger, CFO, certified that the amended report does not contain any untrue statements or omissions and fairly presents the company's financial condition.
- Both the CEO and CFO acknowledged their responsibility for establishing and maintaining internal controls over financial reporting.
Industry Context
The filing of an amended 10-K to correct internal control reporting is not uncommon, but it highlights the importance of robust internal controls and compliance in the healthcare technology sector.
Comparison to Industry Standards
- While the need for an amendment is not ideal, many companies in the technology sector, including those in healthcare, have had to file similar amendments to correct errors or omissions.
- Companies like Cerner (now Oracle Health) and Allscripts have faced scrutiny over internal controls and financial reporting in the past, highlighting the importance of diligence in this area.
- The speed and transparency with which Health Catalyst addressed the issue is a positive sign, as some companies have faced more prolonged issues with internal control weaknesses.
Stakeholder Impact
- Shareholders may have concerns about the initial lapse in internal control reporting.
- The correction of the error should reassure stakeholders about the company's commitment to compliance.
Key Dates
| Date | Description |
|---|---|
| February 6, 2019 | Date of Fifth Amended and Restated Registration Agreement, Investor Rights Agreement, and Stockholders Agreement. |
| June 27, 2019 | Date of various agreements referenced in the exhibit index. |
| July 12, 2019 | Date of various agreements referenced in the exhibit index. |
| August 2, 2021 | Date of Amendment to the Amended and Restated Bylaws. |
| February 28, 2023 | Date of Offer Letter between the Registrant and Kevin Freeman. |
| March 27, 2023 | Date of Offer Letters between the Registrant and Anne Marie Bickmore and Ben Landry. |
| May 10, 2023 | Date of filing of 10-Q referencing offer letters to Anne Marie Bickmore and Ben Landry. |
| June 30, 2023 | Date used to calculate the aggregate market value of common stock held by non-affiliates. |
| December 4, 2023 | Date of Separation and Release Agreement between the Registrant and Anne Marie Bickmore. |
| December 31, 2023 | Fiscal year end date. |
| February 15, 2024 | Date of share count information. |
| February 22, 2024 | Date of original Form 10-K filing. |
| April 23, 2024 | Date of amended Form 10-K/A filing and certifications. |
Keywords
internal control, financial reporting, amendment, 10-K, certification, SEC, compliance, Health Catalyst
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.